July 8 (Reuters) - Star Combo Pharma Ltd (S66) :
- ENTERED INTO AN AGREEMENT TO ACQUIRE 100% OF SHARES IN BIO-E FOR UPFRONT CONSIDERATION OF A$60M
- UPFRONT CONSIDERATION COMPRISES A CASH PAYMENT OF A$42M PLUS ISSUE OF 30M STAR COMBO SHARES AT A$0.60 PER SHARE
- CASH CONSIDERATION TO BE FUNDED VIA A CAPITAL RAISING OF A$51M
- ISSUE PRICE OF A$0.56 PER SHARE
July 8 (Reuters) - Star Combo Pharma Ltd (S66) : ENTERED INTO...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.36M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 88 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 14200 | 2 |
View Market Depth
| Last trade - 16.21pm 15/09/2025 (20 minute delay) ? |
| S66 (ASX) Chart |
Day chart unavailable